Pharmaceuticals News and Research

RSS

Discovery may reduce the environmental impact of chemical manufacturing

Chemical manufacturers frequently use toxic solvents such as alcohols and benzene to make products like pharmaceuticals and plastics.

5 Feb 2021

GSA experts propose strategies to address dementia-related psychosis

A new white paper from The Gerontological Society of America (GSA) highlights the variety of challenges that persons with dementia-related psychosis and their caregivers have encountered during moves through different health care settings -- and proposes strategies to address these challenges.

5 Feb 2021

KHN’s ‘What the Health?’: Covid and kids

Nearly a year into the pandemic, many public schools are still closed to in-person instruction. But while there is increasing evidence that schools are not a major source of infection, teachers and staffers remain concerned about going back to class before they are vaccinated.

4 Feb 2021

Songbird system may provide new treatment options for children with autism

Inactivating a gene in young songbirds that are closely linked with autism spectrum disorder (ASD) prevents the birds from forming memories necessary to accurately reproduce their fathers' songs, a new study led by UT Southwestern shows.

4 Feb 2021

Study shows how tissue damage promotes the earliest stages of pancreatic cancer

Like weeds sprouting from cracks in the pavement, cancer often forms in sites of tissue damage. That damage could be an infection, a physical wound, or some type of inflammation.

4 Feb 2021

European biotech companies rely on AI to deliver COVID-19 vaccine

A high-standard health system, rich health data and a strong research and innovation ecosystem are Europe's key assets that can help transform its health sector and make the EU a global leader in health-related artificial intelligence applications.

4 Feb 2021

100 million covid shots in 100 days doesn’t get us back to normal

April 30 will mark the end of the first 100 days of President Joe Biden's tenure. That's a benchmark presidents often set for making good on high-priority campaign promises.

3 Feb 2021

New gold-nanoparticle probes for target identification of bioactive small molecules

The development of pharmaceutical treatments is difficult -- clinicians and researchers know a certain drug can regulate particular functions, but they might not know how it actually works.

1 Feb 2021

When your chance for a covid shot comes, don’t worry about the numbers

When getting vaccinated against covid-19, there's no sense being picky. You should take the first authorized vaccine that's offered, experts say.

1 Feb 2021

Sepha Launches Small Batch Contract Packaging Service

Sepha, the Northern Ireland based specialist in pharmaceutical packaging and machinery, has launched a contract packaging service to meet rising demand for small batch production.

1 Feb 2021

Researchers explore how the current practice of nephrology may have racist ideologies

There is a growing awareness of systematic inequality and structural racism in American society. Science and medicine are no exception, as evidenced by historical instances of discrimination and overt racism.

30 Jan 2021

Vitamins and other antiviral drugs may help combat COVID-19

Evidence is emerging that vitamin D - and possibly vitamins K and A - might help combat COVID-19. A new study from the University of Bristol published in the journal of the German Chemical Society Angewandte Chemie has shown how they - and other antiviral drugs - might work.

29 Jan 2021

KHN’s ‘What the Health?’: The long road to unwinding Trump health policies

Thursday was "health day" in President Joe Biden's sprint to launch his presidency, and he signed two executive orders addressing health coverage and women's reproductive rights.

28 Jan 2021

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Researchers have described the potential of the drug spironolactone, a potassium-sparing diuretic, and anti-androgen, in preventing or alleviating the severity of COVID-19 pneumonia, and in preventing pulmonary fibrosis.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

If I have cancer, dementia or MS, should i get the covid vaccine?

As public demand grows for limited supplies of covid-19 vaccines, questions remain about the vaccines' appropriateness for older adults with various illnesses.

27 Jan 2021

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

A Purdue University-affiliated startup is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.

27 Jan 2021

Why even presidential pressure might not get more vaccine to market faster

Americans are dying of covid-19 by the thousands, but efforts to ramp up production of potentially lifesaving vaccines are hitting a brick wall.

26 Jan 2021

Experts focus on identifying key research priorities related to AF screening

Atrial fibrillation (AF) is associated with a higher risk of complications including ischemic stroke, cognitive decline, heart failure, myocardial infarction and death. AF frequently is undetected until complications such as stroke or heart failure occur.

26 Jan 2021

Herd immunity to SARS-CoV-2 may not be achievable with current vaccines

A recent preprint research paper posted on the medRxiv server asks the question: “Is “herd immunity” to COVID-19 a realistic outcome of any immunization program with the two main vaccines currently licensed in the UK?”

25 Jan 2021